Avinger, Inc. (AVGR)
USD 0.49
(-3.35%)
USD 0.49
(-3.35%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.29 Million USD | 6.71% |
| 2022 | 4.96 Million USD | 7.91% |
| 2021 | 4.6 Million USD | 18.7% |
| 2020 | 3.87 Million USD | -0.92% |
| 2019 | 3.91 Million USD | 14.32% |
| 2018 | 3.42 Million USD | -20.33% |
| 2017 | 4.29 Million USD | -49.24% |
| 2016 | 8.46 Million USD | 56.56% |
| 2015 | 5.4 Million USD | 35.43% |
| 2014 | 3.99 Million USD | -15.82% |
| 2013 | 4.74 Million USD | 34.8% |
| 2012 | 3.51 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 4.12 Million USD | -9.69% |
| 2024 Q1 | 4.56 Million USD | -13.89% |
| 2023 Q2 | 5.51 Million USD | 3.8% |
| 2023 FY | 5.29 Million USD | 6.71% |
| 2023 Q1 | 5.31 Million USD | 7.09% |
| 2023 Q4 | 5.29 Million USD | -5.05% |
| 2023 Q3 | 5.58 Million USD | 1.11% |
| 2022 Q4 | 4.96 Million USD | -1.62% |
| 2022 Q3 | 5.04 Million USD | -2.53% |
| 2022 FY | 4.96 Million USD | 7.91% |
| 2022 Q1 | 5.35 Million USD | 16.28% |
| 2022 Q2 | 5.17 Million USD | -3.21% |
| 2021 Q2 | 4.11 Million USD | 4.62% |
| 2021 Q3 | 4.51 Million USD | 9.74% |
| 2021 Q4 | 4.6 Million USD | 1.81% |
| 2021 FY | 4.6 Million USD | 18.7% |
| 2021 Q1 | 3.93 Million USD | 1.55% |
| 2020 Q1 | 3.87 Million USD | -0.95% |
| 2020 Q4 | 3.87 Million USD | -2.95% |
| 2020 Q3 | 3.99 Million USD | -3.92% |
| 2020 FY | 3.87 Million USD | -0.92% |
| 2020 Q2 | 4.15 Million USD | 7.28% |
| 2019 Q1 | 3.95 Million USD | 15.58% |
| 2019 Q2 | 4.1 Million USD | 3.79% |
| 2019 Q4 | 3.91 Million USD | -4.86% |
| 2019 Q3 | 4.11 Million USD | 0.17% |
| 2019 FY | 3.91 Million USD | 14.32% |
| 2018 Q1 | 4 Million USD | -6.71% |
| 2018 FY | 3.42 Million USD | -20.33% |
| 2018 Q4 | 3.42 Million USD | -0.81% |
| 2018 Q3 | 3.45 Million USD | -5.51% |
| 2018 Q2 | 3.65 Million USD | -8.88% |
| 2017 Q3 | 5.04 Million USD | -24.68% |
| 2017 FY | 4.29 Million USD | -49.24% |
| 2017 Q4 | 4.29 Million USD | -14.88% |
| 2017 Q2 | 6.69 Million USD | -19.79% |
| 2017 Q1 | 8.35 Million USD | -1.3% |
| 2016 Q1 | 6.54 Million USD | 21.0% |
| 2016 Q3 | 7.08 Million USD | 2.21% |
| 2016 Q2 | 6.92 Million USD | 5.92% |
| 2016 Q4 | 8.46 Million USD | 19.52% |
| 2016 FY | 8.46 Million USD | 56.56% |
| 2015 FY | 5.4 Million USD | 35.43% |
| 2015 Q1 | 4.04 Million USD | 1.35% |
| 2015 Q2 | 3.75 Million USD | -7.07% |
| 2015 Q4 | 5.4 Million USD | 68.64% |
| 2015 Q3 | 3.2 Million USD | -14.74% |
| 2014 Q2 | 4.05 Million USD | 0.0% |
| 2014 FY | 3.99 Million USD | -15.82% |
| 2014 Q4 | 3.99 Million USD | -8.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q3 | 4.33 Million USD | 6.87% |
| 2013 FY | 4.74 Million USD | 34.8% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | 4.74 Million USD | 0.0% |
| 2012 FY | 3.51 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 70.364% |
| AngioDynamics, Inc. | 60.61 Million USD | 91.26% |
| AtriCure, Inc. | 67.89 Million USD | 92.197% |
| Azenta, Inc. | 128.19 Million USD | 95.867% |
| BioLife Solutions, Inc. | 43.45 Million USD | 87.808% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.28% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -4.911% |
| Femasys Inc. | 667.11 Thousand USD | -694.162% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 78.564% |
| Hologic, Inc. | 679.8 Million USD | 99.221% |
| ICU Medical, Inc. | 709.36 Million USD | 99.253% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.566% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -52.184% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 89.876% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -518.377% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -518.377% |
| Masimo Corporation | 545 Million USD | 99.028% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -227.598% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 98.256% |
| Nephros, Inc. | 2.47 Million USD | -114.494% |
| NovoCure Limited | 38.15 Million USD | 86.113% |
| NEXGEL, Inc. | 1.31 Million USD | -301.668% |
| NEXGEL, Inc. | 1.31 Million USD | -301.668% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 60.964% |
| OraSure Technologies, Inc. | 47.61 Million USD | 88.873% |
| Pro-Dex, Inc. | 15.26 Million USD | 65.302% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -971.658% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -84.722% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.083% |
| Repligen Corporation | 202.32 Million USD | 97.381% |
| Sanara MedTech Inc. | 4.71 Million USD | -12.304% |
| STAAR Surgical Company | 35.13 Million USD | 84.919% |
| Sharps Technology, Inc. | 1.7 Million USD | -209.981% |
| Utah Medical Products, Inc. | 9.58 Million USD | 44.709% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.151% |
| Jin Medical International Ltd. | 5.05 Million USD | -4.846% |